Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Leukemia Research|March 5, 2015
Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failureStéphanie Harel, Amina Cherait, Céline Berthon, et al.
Blood|October 11, 2007
Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical studySimone Boehrer, Lionel Adès, Thorsten Braun, et al.
Haematologica|April 16, 2026
An unusual case of basophilic meningitis revealing a chronicphase chronic myeloid leukemia: a report after almost three years of follow-upRamy Rahmé, Matteo Dragani, Carole Fleury, et al.
Cell Cycle (Georgetown, Tex.)|September 8, 2011
Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemiaSimone Boehrer, Lorenzo Galluzzi, Elodie Lainey, et al.
Oncotarget|May 21, 2015
BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cellsMarie-Magdelaine Coudé, Thorsten Braun, Jeannig Berrou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2011
Outcome of high-risk myelodysplastic syndrome after azacitidine treatment failureThomas Prébet, Steven D Gore, Benjamin Esterni, et al.
Blood|March 18, 2009
The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplicationAline Renneville, Nicolas Boissel, Nathalie Gachard, et al.
Journal of Clinical Medicine|November 26, 2022
Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (<i>BCR::ABL+</i>) Acute Lymphoblastic Leukemia (ALL)Jeannig Berrou, Mélanie Dupont, Hanane Djamai, et al.
Leukemia & Lymphoma|December 8, 2011
Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trialGiovanna Cannas, Cécile Pautas, Emmanuel Raffoux, et al.
Ejhaem|March 20, 2025
Bortezomib, Rituximab and Dexamethasone Regimen (BDR) in Waldenström Macroglobulinaemia: A Retrospective Real-World AnalysisThomas Hueso, Grégory Lazarian, Paul Chauvet, et al.
Pageof 8